Total Returns (Price + Dividend) 
EP Biocomposites for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Financial Results For The Half Year Ended September 30 2026 Along With The Management Commentary
13-Nov-2026 | Source : BSEFinancial results for the half year ended September 30 2026 along with the management commentary
Financial Results And Management Commentary For The Half Year Ended September 30 2026
13-Nov-2026 | Source : BSEFinancial results and management commentary for the half year ended September 30 2026
Board Meeting Intimation for Half Yearly Results For The Half Year Ended September 30 2026
06-Nov-2026 | Source : BSEEP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 inter alia to consider and approve Half yearly results for the half year ended September 30 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Leena Rajkumar Kamat (64.93%)
Kavita Kumar Santosh (2.32%)
26.71%
Half Yearly Results Snapshot (Standalone) - Mar'25
Growth in half year ended Mar 2025 is 72.73% vs -37.50% in Sep 2024
Growth in half year ended Mar 2025 is 295.24% vs -77.42% in Sep 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 4.98% vs 60.45% in Mar 2024
YoY Growth in year ended Mar 2025 is -10.43% vs 98.28% in Mar 2024